# Huyong Zheng

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/huyong-zheng/

## Facts

| Field | Value |
| --- | --- |
| Citations | 815 |
| Field | Acute Lymphoblastic Leukemia research |
| h-index | 14 |
| i10-index | 21 |
| Last Known Institution | Capital Medical University |
| OpenAlex ID | https://openalex.org/A5103260988 |
| ORCID iD | 0000-0002-6220-2789 |
| Works | 57 |

## Researcher papers

- [Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG‐ALL 2008: The first nation‐wide prospective multicenter study in China](https://scholariq.org/papers/outcome-of-children-with-newly-diagnosed-acute-lymphoblastic-leukemia-treated/)
- [Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of <i>EP300</i> and <i>CREBBP</i>](https://scholariq.org/papers/whole-transcriptome-sequencing-identifies-a-distinct-subtype-of-acute/)
- [Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia](https://scholariq.org/papers/polymorphisms-in-methotrexate-transporters-and-their-relationship-to-plasma/)
- [miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase](https://scholariq.org/papers/mir-130a-can-predict-response-to-temozolomide-in-patients-with-glioblastoma/)
- [Medication therapy of high‐dose methotrexate: An evidence‐based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society](https://scholariq.org/papers/medication-therapy-of-high-dose-methotrexate-an-evidence-based-practice/)
- [Gene expression–based classification and regulatory networks of pediatric acute lymphoblastic leukemia](https://scholariq.org/papers/gene-expression-based-classification-and-regulatory-networks-of-pediatric-acute/)
- [Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia](https://scholariq.org/papers/expression-of-mir-652-3p-and-effect-on-apoptosis-and-drug-sensitivity-in/)
- [Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children](https://scholariq.org/papers/clinical-biological-characteristics-and-treatment-outcomes-of-pediatric-pro-b/)
- [<i><scp>NOTCH</scp>1</i> mutations are associated with favourable long‐term prognosis in paediatric <scp>T</scp>‐cell acute lymphoblastic leukaemia: a retrospective study of patients treated on <scp>BCH</scp>‐2003 and <scp>CCLG</scp>‐2008 protocol in <scp>C</scp>hina](https://scholariq.org/papers/i-scp-notch-scp-1-i-mutations-are-associated-with-favourable-long-term-prognosis/)
- [The prognostic potential of coilin in association with p27 expression in pediatric acute lymphoblastic leukemia for disease relapse](https://scholariq.org/papers/the-prognostic-potential-of-coilin-in-association-with-p27-expression-in/)
- [\[Clinical characteristics and prognostic factors of epidermal growth factor receptor-mutated non-small cell lung cancer transformed into small-cell lung cancer after treatment\].](https://scholariq.org/papers/clinical-characteristics-and-prognostic-factors-of-epidermal-growth-factor/)

## Researcher topics

- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Researcher university

- [Capital Medical University](https://scholariq.org/institutions/capital-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.